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Abstract: Aims: The aim of this study was to evaluate the physicochemical properties of the pleural mesothelial barrier 
and of the biological markers that facilitate or eliminate the passage of molecules through the pleura. 
Methods and Material: Pleural fluid samples from sixty-five patients with heart failure were analyzed. The biological 
markers studied were lactate dehydrogenase (LDH), adenosine deaminase (ADA), interleukin-6 (IL-6), C-reactive protein 
(CRP), tumor necrosis factor- (TNF-), carcinoembryonic antigen (CEA), copper/zinc superoxide dismutase 
(CuZnSOD), matrix metalloproteinase-2 (MMP-2), -3 (MMP-3), -7(MMP-7), -8 (MMP-8) and -9 (MMP-9). Based on the 
pleural fluid/serum ratio, these molecules were divided into three groups: a) the LDH-like group with a pleural 
fluid/serum ratio between 0,4 and 0,8 (LDH, CEA, CuZnSOD, ADA, CRP, MMP-8), b) molecules with a pleural 
fluid/serum ratio less than 0,4 (MMP-7 and MMP-9) and c) molecules with a pleural fluid/serum ratio equal or above 1 
(TNF-, IL-6, MMP-2 and MMP-3). 
Results: No correlation between the molecular radius and the pleural fluid to serum ratio of the above biological markers 
was found. 
Conclusions: The molecular size is not a major determinant for the passage of molecules through the mesothelial barrier. 
Several other factors may influence the transport of the above molecules to pleural cavity, such as their charge and shape. 
Keywords:  Biological markers, mesothelial barrier, pleural fluid/ serum ratio, transudates, lactate dehydrogenase, tumor 
necrosis factor. 
INTRODUCTION 
  The first question to answer when a patient with an 
undiagnosed pleural effusion is evaluated is whether this 
effusion is a transudate or an exudate. The criteria 
established by Light
 [1] have become the “gold standard” for 
segregating transudative from exudative pleural effusions, 
especially because of their high sensitivity. This distinction 
determines not only the differential diagnosis and thus the 
following therapeutic intervention, but also the underlying 
pathophysiologic mechanisms which lead to the aggregation 
of fluid in the pleural cavity. Indeed, an exudative pleural 
effusion occurs when the permeability of the mesothelial-
capillary barrier to albumin and other macromolecules is 
elevated. In contrast, the presence of a transudate indicates 
that the systemic or pulmonary pressures influencing the 
formation or reabsorption of pleural fluid are altered [2]. 
Because the barrier permeability characteristics are 
maintained to transudates, the transpleural transport of 
molecules is the same as in normal conditions. The aim of 
this study was to estimate the physicochemical properties of 
the pleural mesothelial barrier and of biological markers that  
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facilitate or eliminate their passage through the pleura. More 
specifically we hypothesized that molecular size, a physical 
property which may be represented by molecular radius, 
determines the passage of substances through the mesothelial 
barrier to the pleural cavity 
SUBJECTS AND METHODS 
  We enrolled 65 patients with transudative pleural 
effusions who were admitted to the Respiratory Medicine 
Department of University Hospital of Larissa from 
September 2007 through February 2009. Local ethics 
committee approved the study protocol and all subjects 
provided written informed consent. 
  After the first successful thoracentesis of pleural fluid, 
samples were subjected to routine biochemical analysis 
including tests for glucose, total protein and LDH. In 
addition, samples were analyzed for total cell count and 
differential cell count. For biomarker’s measurements, 
pleural fluid were immediately centrifuged at 1500g for 15 
min at 4
0C to pellet the cellular elements and the 
supernatants were stored at -80
0C until the final procedure. 
Venous blood was also drawn for serum analysis and 
processed in the same way as the pleural fluid. ADA activity 
was
  measured by the colorimetric method of Giusti. CEA 
concentration levels
  were determined using an 
electrochemiluminescence immunoassay
  on the Roche Pleural Transport Physiology  The Open Respiratory Medicine Journal, 2011, Volume 5    71 
Modular E 170 analyser (Roche Diagnostics, Mannheim,
 
Germany). CRP measurements
  were performed by 
immunonephelometry with the Behring Nephelometer
 
Analyzer II, using the N High Sensitivity kit (Dade Behring,
 
Marburg, Germany), according to the manufacturer’s 
instructions. IL-6, TNF-, CuZnSOD and MMPs levels were 
measured with commercially available enzyme-
immunosorbent assay kits (Biosource, Europe S.A., Bender 
MedSystems, Austria Europe and R&D Systems, 
Minneapolis MN USA), according to the manufacturer’s 
protocols. 
  The patients were classified into exudate or transudate 
groups based on the clinical and laboratory findings of 
pleural effusions obtained by thoracentesis. Only patients 
with a transudative pleural effusion which was attributed to 
left heart failure were included in this study. Patients with 
traumatic thoracentesis were excluded from the study. Cut-
off values for differentiating exudates from transudates were 
determined with the criteria of Light et al. as follows: pleural 
fluid to serum protein ratio>0.5, or pleural fluid to serum 
lactate dehydrogenase (LDH) ratio>0.6, or pleural fluid LDH 
greater than two-thirds of the upper limit of normal serum 
LDH level. Pleural effusion was defined as exudate when 
one or more of these findings were recognized [1]. 
  In order to test our hypothesis, the pleural fluid to serum 
ratio of lactate dehydrogenase (LDH), adenosine deaminase 
(ADA), C-reactive protein (CRP), carcinoembryonic antigen 
(CEA), interleukin-6 (IL-6), tumor necrosis factor-a (TNF-
), copper/zinc superoxide dismutase (CuZnSOD) and 
matrix metalloproteinases (MMPs) [MMP-2, MMP-3, 
MMP-7, MMP-8, MMP-9] to patients with transudative 
pleural effusions. Based on the pleural fluid to serum ratio 
we can classify the biological markers to three subgroups: a) 
the LDH–like group with a pleural fluid to serum ratio   
 
between 0.4 and 0.8. Here belongs the majority of the 
molecules studied, i.e. LDH, CEA, CuZnSOD, ADA, CRP, 
MMP-8, b) molecules with a pleural fluid to serum ratio less 
than 0.4. MMP-7 and MMP-9 are included to this group c) 
molecules with a pleural fluid to serum concentration equal 
or above 1, to which TNF-, IL-6 and MMP-2 and MMP-3 
are included. The molecular radius of the biological markers 
was calculated according to the following empirical 
equation: a = 0.483 x (MW) 
0.385, where a is the molecular 
radius in Å and MW the molecular weight in Dalton [3]. 
This equation was calculated by Rippe and Stelin in order to 
evaluate the transperitoneal clearance of molecules with 
divergent MWs through pores of a wide range of radius. 
  Statistical analysis was performed using SPSS for 
Windows (SPSS, Chicago, USA). For mean values Student’s 
t-test was performed. Spearman r test was used for 
correlation analysis. P<0.05 was regarded as significant. 
RESULTS 
  Mean value of all twelve biological markers measured in 
pleural fluid and serum and their standard deviation are 
presented in Table 1. Also the mean value of the pleural 
fluid/serum ratio, standard deviation and minimum and 
maximum value of the twelve biological markers measured to 
transudates are shown in Table 1. The lowest ratio was observed 
for MMP-9 (0.09) whereas the highest for IL-6 (29.27). 
  No statistically significant correlation was found between 
the pleural fluid/serum ratio and the molecular radius of the 
molecules (correlation coefficient r = -0.339, p = 0.279). 
When we examined solely the biological markers with a 
molecular radius less than 30 Å (ADA, CuZnSOD, MMP-7, 
TNF- and IL-6), the correlation coefficient between the 
molecular radius and the pleural fluid/serum ratio was -0.705 
and it was not statistically significant (p value=0.117). 
Table 1.  Biological Markers Measured in Pleural Fluid, According to Pleural Fluid/Serum Ratio Value 
 
  Pleural Fluid/Serum Ratio 
Molecule  MW
a  Molecular Radius
b  Pleural Fluid Mean (SD
c)  Serum Mean (SD
c)  Mean (SD)  Minimum Value  Maximum Value 
ADA   42   29.10  8.52 (3.26)  22.75 (8.37)   0.40 (0.17)  0.13   0.82 
CRP  115   42.88  0.84 (0.76)  2.22 (1.61)   0.50 (0.63)  0.05  3.50 
LDH  134   45.48  122 (62)  232 (88)  0.60 (0.48)  0.22  2.71 
CEA  180   50.95  1.05 (0,69)  2.20 (1.56)   0.60 (0.51)  0.15  2.47 
CuZnSOD  31   26.08  98.38 (50)  210 (139)   0.64 (0.37)  0.07  1.55 
MMP-8  85   38.61  14.76 (5.2)  42.06 (12)  0.80 (2.87)  0.00  12.82 
               
MMP-9  92   39.35  33.19 (15)  598 (226)   0.09 (0.26)  0.00  1.24 
MMP-7  28   24.89  1.61 (2.29)  7.11 (2.78)  0.22 (0.24)  0.03  1.31 
               
TNF-  17   20.72  18.78 (11.78)  20.74 (14.21)  1.04 (0.57)  0.40  2.63 
MMP-3  57   32.73  28 (16)  25.41 (19.77)  1.40 (0.86)  0.27  3.53 
MMP-2  72   35.81  422.2 (122.2)  232.4 (68.21)  1.89 (0.46)  0.97  3.19 
IL-6  20   21.99  43.82 (42.66)  29.27 (38.54)   29.27 (38.54)  5.09  208.60 
a: molecular weight in kDa, b: molecular radius in Å, c: standard deviation. The mean value in pleural fluid and serum is given in ng/ml for MMPs, CuZnSOD, CEA, IU/L for ADA 
and LDH, mg/dl for CRP and pg/ml for IL-6 and TNF-. 72    The Open Respiratory Medicine Journal, 2011, Volume 5  Eleni et al. 
DISCUSSION 
  Based on the pleural fluid to serum ratio we classified the 
biological markers into three subgroups. The small ratio for 
MMP-7 and MMP-9 implies that these molecules can hardly 
transverse the mesothelial barrier from the blood circulation 
of the pleura to the pleura cavity. On the other hand, the 
local production of the MMP-2 and IL-6 by mesothelial cells 
and subsequent secretion to pleural cavity results to a high 
pleural fluid/serum ratio above unit [4].
 For MMP-3 no study 
has been conducted regarding the expression of this enzyme 
by mesothelial cells. TNF-a is found to almost similar 
concentrations in blood circulation and pleural cavity 
(pleural fluid/serum concentration 1.04), and this reflects the 
convenience of this molecule to diffuse through the 
mesothelial barrier. It has been suggested that some of the 
above biological markers, either alone or combined, can 
contribute to the discrimination between the different kinds 
of exudative effusions [5, 6]. However, the factors that 
determine the transport of a molecule to pleural cavity, under 
conditions of normal or increased permeability, remain 
unknown. 
Is Molecular Radius a Major Determinant for the 
Passage of Molecules Through the Pleura? 
  No correlation between molecular radius and pleural 
fluid/serum ratio of all twelve biological markers was found. 
At the peritoneal membrane of the abdominal cavity and at 
glomerular filter of the kidney it has been shown that small 
solutes (molecular radius < 30 Å) transport, through the 
peritoneal and glomerulal filter respectively, via  diffusion. 
This means that osmotic pressure gradients determine the 
movement of small solutes. A different mechanism occurs 
for the transport of proteins and macromolecules (molecular 
radius   30 Å), as these solutes transport primarily via 
filtration, that is hydrostatic pressures lead the transport of 
macromolecules [7, 8]. Filtration does not depend on the 
MW and on the molecular radius of a solute whereas 
diffusion does. When we examined only the biological 
markers with a low molecular radius < 30 Å, which 
theoretically transport via diffusion, again no correlation was 
found. The above indicate that the mesothelial barrier is not 
primarily size-restrictive. Other factors, such as discussed 
below, may determine the passage of molecules to the 
pleural cavity. 
Pathophysiological Significance 
  The properties that influence the sieving characteristics 
of the pleura can be divided in two main categories: i) the 
structure of mesothelial barrier, consisting of microvascular 
capillaries of the pleura and the mesothelial monolayer and 
ii) the physiochemical properties of the molecules. Pleural 
fluid is produced at parietal pleural level and represents a 
filtrate through capillary endothelium of the pleura and 
mesothelial cells [9]. For microvascular endothelium 
permeability, it has been suggested that small solutes (up to 
the size of albumin) diffuse through “small pores”, 
represented by clefts in the intercellular junctions. In 
contrary, macromolecules use a population of “large pores”, 
which could either be real openings between cells or be 
provided by an intracellular vesicular system [10].
 No study 
on the microscopic structure of “small pores” located to 
mesothelium has been so far conducted. Macromolecule 
transfer to mesothelium mainly occurs through “large pores” 
[11]. The morphological counterpart for large pores is not 
known. Although cytoplasmic vesicles have been well 
described to mesothelial cells, these seem to account only for 
reabsorption of pleural fluid and not for its production. The 
microscopic structure of “small and large pores” should be 
an important factor to determine the feasibility of molecules 
to pass through the mesothelial barrier. Other factors that 
may influence the passage of molecules to pleural cavity 
involve the molecular radius, net charge, deformability and 
shape of molecules and their connection to plasma proteins, 
such as albumin. 
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